[ad_1]
Expert staff of the Food and Drug Administration (FDA) Supported the recommendation from the United States Johnson & Johnson coronavirus vaccine booster dose More than 18 years.
The FDA’s Vaccine and Related Biology Advisory Committee unanimously approved the recommendation for a second dose. at least two months after the first applicationThis was reported by the American network CNN This was reported by DPA.
Now, the FDA will have to evaluate the recommendation and decide to approve it, after which the decision will go to the Centers for Disease Control and Prevention.
/ Internal Code House /
Take another look
Fight against coronavirus
/ End Placement Code /
The panel’s decision is based on the results of Phase 3, which showed that booster vaccines increase protection against moderate to severe coronavirus in the United States by 94 percent.
“Today’s recommendation is based on a body of evidence, and clinical and real-world data show that a single vaccine provides strong and long-term protection, but is a booster dose administered after initial vaccination. Against symptomatic Covid-19,” said Johnson & Johnson Executive Committee. Deputy Chairman and Senior Research Fellow Paul Stoffels.
Second, On Thursday, FDA experts recommended Modern Enhancement Vaccines for people over 65 and other high-risk adults..
[ad_2]
Source link
